Venetoclax
Showing 1 - 25 of 485
Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)
Not yet recruiting
- Light Chain (AL) Amyloidosis
- +2 more
- Venetoclax
- Dexamethasone Oral
- (no location specified)
Aug 16, 2023
Healthy Volunteers Trial in Grayslake (Venetoclax)
Recruiting
- Healthy Volunteers
- Venetoclax
-
Grayslake, IllinoisAcpru /Id# 259897
Oct 2, 2023
AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)
Recruiting
- AML
- MDS
- Decitabine
- Venetoclax
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital
Nov 30, 2023
Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination
Not yet recruiting
- Elderly AML Patients
- +4 more
- Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
- Active Comparator: Standard dose of Venetoclax + Azacitidine
-
Kunming, Yunnan, ChinaThe Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +5 more
- Nemtabrutinib
- +2 more
- (no location specified)
Jul 21, 2023
Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)
Recruiting
- Hypomethylating Agent
- +2 more
- Venetoclax
- Azacitidine or decitabine
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Venetoclax
-
Birmingham, AlabamaA. Brent Carter
Aug 3, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 5, 2022
Chronic Myeloid Leukemia Trial in Jena (Venetoclax)
Not yet recruiting
- Chronic Myeloid Leukemia
- Venetoclax
-
Jena, GermanyUniversitätsklinikum Jena
Jan 17, 2023
Healthy Volunteers Trial in Grayslake (Venetoclax)
Recruiting
- Healthy Volunteers
- Venetoclax
-
Grayslake, IllinoisAcpru /Id# 255783
Jun 21, 2023
Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 23, 2023
Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia
- Azacitidine and Venetoclax
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 1, 2022
Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)
Not yet recruiting
- Mantle Cell Lymphoma Refractory
- Ibrutinib
- +3 more
- (no location specified)
May 16, 2023
AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)
Not yet recruiting
- AML/MDS
- +2 more
- Danvatirsen
- Danvatirsen + Venetoclax
- (no location specified)
Aug 14, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- Venetoclax
- (no location specified)
Oct 30, 2023
Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)
Not yet recruiting
- Acute Myeloid Leukemia
- Pharmacokinetic sampling
- +3 more
-
Marseille, France
- +1 more
Sep 6, 2023
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
-
Suzhou, Jiangsu, ChinaQiu Huiying
Mar 28, 2023
Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)
Recruiting
- Acute Myeloid Leukemia Refractory
- NP137
- +2 more
-
Lyon, FranceCentre Léon Bérard
Nov 30, 2023
Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)
Not yet recruiting
- Multiple Myeloma
- Multiple Myeloma in Relapse
- Belantamab mafodotin, Venetoclax
- (no location specified)
May 10, 2023
Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)
Recruiting
- Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
- Olverembatinib plus venetoclax and dexamethasone
-
Xi'an, Shannxi, ChinaDepartment of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023
Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)
Not yet recruiting
- Waldenstrom Macroglobulinemia
- Venetoclax; Rituximab
- DRC
- (no location specified)
Nov 4, 2022
Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Venetoclax
- +5 more
- (no location specified)
May 9, 2023
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
- Venetoclax
- Decitabine
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023